EMEA-002974-PIP01-21
Key facts
Active substance |
Benzylamine derivative of benzofuran (BCX9930)
|
Therapeutic area |
Haematology-Hemostaseology
|
Decision number |
P/0125/2022
|
PIP number |
EMEA-002974-PIP01-21
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of paroxysmal nocturnal haemoglobinuria
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
BioCryst Ireland Limited
|
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|